ACURX PHARMACEUTICALS INC (ACXP) Forecast, Price Target & Analyst Ratings

NASDAQ:ACXP • US00510M2035

Current stock price

4.28 USD
-0.25 (-5.41%)
At close:
4.54 USD
+0.26 (+6.07%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACURX PHARMACEUTICALS INC (ACXP).

Forecast Snapshot

Consensus Price Target

Price Target
$62.93
+ 1,370.42% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.65
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$62.93
Upside
+ 1,370.42%
From current price of $4.28 to mean target of $62.93, Based on 9 analyst forecasts
Low
$20.20
Median
$31.11
High
$174.09

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ACXP. The average price target is 62.93 USD. This implies a price increase of 1370.42% is expected in the next year compared to the current price of 4.28.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ACXP Current Analyst RatingACXP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ACXP Historical Analyst RatingsACXP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
ACXP was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ACXP.
In the previous month the buy percentage consensus was at a similar level.
ACXP was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-09-30HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-12HC Wainwright & Co.Maintains Buy -> Buy
2025-03-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-19HC Wainwright & Co.Maintains Buy -> Buy
2024-02-28HC Wainwright & Co.Reiterate Buy -> Buy
2023-12-15HC Wainwright & Co.Maintains Buy -> Buy
2023-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-15HC Wainwright & Co.Maintains Buy -> Buy
2023-05-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-04-11HC Wainwright & Co.Reiterate Buy
2023-03-17HC Wainwright & Co.Reiterate Buy
2022-12-19HC Wainwright & Co.Initiate Buy
2021-11-29Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.65
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
70.56%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
46.64%
EPS (3 Months)
46.64%

Next Earnings Summary

ACXP is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.65 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACXP revenue by date.ACXP revenue by date.
N/AN/AN/AN/AN/A
81.43%		N/A
30.51%		N/A
47.97%		N/A
34.14%
EBITDA
YoY % growth
ACXP ebitda by date.ACXP ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
-6.90%		N/A
-9.68%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACXP ebit by date.ACXP ebit by date.
-5.93M-4.6M
22.43%		-12.82M
-178.70%		-12.09M
5.69%		-14.578M
-20.58%		-14.103M
3.26%		-8.092M
42.62%		N/A
-17.44%		N/A
-55.10%		N/A
-54.38%		N/A
146.02%		N/A
307.39%		N/A
49.69%		N/A
74.48%		N/A
44.96%
Operating Margin
ACXP operating margin by date.ACXP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACXP eps by date.ACXP eps by date.
N/AN/AN/AN/A
29.59%		-22.80
6.08%		-17.40
23.68%		-5.63
67.64%		N/A
31.15%		N/A
8.16%		N/A
-359.03%		N/A
68.29%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.65
70.56%		-1.11
41.44%		-0.70
43.20%		-0.72
-133.61%
Revenue
Q2Q % growth		N/AN/AN/A
EBITDA
Q2Q % growth		-1.836MN/AN/AN/A
EBIT
Q2Q % growth		-3.871M
-80.11%		-4.039M
-77.96%		-4.376M
-115.69%		-4.544M
-181.00%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ACXP Yearly Revenue VS EstimatesACXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 50M 100M 150M 200M
ACXP Yearly EPS VS EstimatesACXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-42.64%
EPS Next 5 Year
1.93%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ACURX PHARMACEUTICALS INC / ACXP Forecast FAQ

What is the average price target for ACURX PHARMACEUTICALS INC (ACXP) stock?

9 analysts have analysed ACXP and the average price target is 62.93 USD. This implies a price increase of 1370.42% is expected in the next year compared to the current price of 4.28.

What is the next earnings date for ACXP stock?

ACURX PHARMACEUTICALS INC (ACXP) will report earnings on 2026-05-11.

What are the consensus estimates for ACURX PHARMACEUTICALS INC (ACXP) next earnings?

The consensus EPS estimate for the next earnings of ACURX PHARMACEUTICALS INC (ACXP) is -0.65 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for ACURX PHARMACEUTICALS INC stock?

The consensus rating for ACURX PHARMACEUTICALS INC (ACXP) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.